BlackRock Advisors’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$421K Buy
16,723
+1,152
+7% +$29.1K ﹤0.01% 2297
2016
Q3
$437K Buy
15,571
+1,285
+9% +$32.9K ﹤0.01% 2247
2016
Q2
$352K Buy
14,286
+300
+2% +$7.44K ﹤0.01% 2305
2016
Q1
$309K Buy
13,986
+814
+6% +$21.7K ﹤0.01% 2322
2015
Q4
$461K Sell
13,172
-6,183
-32% -$194K ﹤0.01% 2116
2015
Q3
$551K Sell
19,355
-738
-4% -$24.8K ﹤0.01% 2132
2015
Q2
$669K Buy
20,093
+892
+5% +$27.4K ﹤0.01% 1964
2015
Q1
$541K Buy
19,201
+2,824
+17% +$70.2K ﹤0.01% 2017
2014
Q4
$339K Sell
16,377
-697
-4% -$16.5K ﹤0.01% 2283
2014
Q3
$417K Sell
17,074
-362
-2% -$9.6K ﹤0.01% 2112
2014
Q2
$498K Sell
17,436
-3,122
-15% -$86.8K ﹤0.01% 2021
2014
Q1
$575K Buy
20,558
+729
+4% +$17.9K ﹤0.01% 1947
2013
Q4
$426K Sell
19,829
-75,149
-79% -$1.37M ﹤0.01% 2150
2013
Q3
$1.26M Sell
94,978
-28,642
-23% -$386K ﹤0.01% 1315
2013
Q2
$1.71M Buy
+123,620
New +$1.75M ﹤0.01% 1166

Other funds holding PMC

BlackRock Advisors's PMC Position: Q4 2016 in Review

BlackRock Advisors increased its PharMerica Corporation (PMC) stake by 7.4% in Q4 2016, buying an estimated $29.1K and bringing the position to 16,723 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #2297.

BlackRock Advisors first reported a position in PMC in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.71M in Q2 2013. 166 funds tracked by Wall St. Rank hold PMC as of Q4 2016.

  • BlackRock Advisors held 16,723 shares of PharMerica Corporation worth $421K as of Q4 2016.
  • BlackRock Advisors bought 1,152 PharMerica Corporation shares in Q4 2016, an estimated $29.1K.
  • PharMerica Corporation made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2297 holding.
  • BlackRock Advisors first reported a position in PharMerica Corporation in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's PharMerica Corporation position peaked at $1.71M in Q2 2013.
  • 166 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.